Abstract
In recent years, Artificial Intelligence (AI) and Machine Learning technologies have played an emerging trend aiding in the creation of new medicines. Simply said, deep learning algorithms and artificial neural networks have brought a new level of sophistication to this field. In recent years, Artificial Intelligence through Machine Learning have been used in this area, and its use is supported by historical data. Additionally, freshly created modelling algorithms relied heavily on unique data mining, duration, and management strategies, which were compared to gauge overall efficiency. This paper suggests the AI powered Drug Detection System using Bioactivity Prediction and Drug Release Tracking. The experimental findings show that the suggested systems effectively recognize the illegal drug advertisements. Datasets with millions of posts gathered using the Google+ API have been used to meticulously verify both the methods. The experimental evidence shows that both approaches can be used to accurately identify medicines.
References
Xing J, Wenchao L, Liu R, Wang Y, Xie Y, Zhang H, Shi Z, Jiang H, Liu Y-C, Chen K et al (2017) Machinelearning-assisted approach for discovering novel inhibitors targeting bromodomain-containing protein 4. J Chem Inf Model 57(7):1677–1690.
Xue LC, Dobbs D, Bonvin AMJJ, Honavar V (2015) Computational prediction of protein interfaces: A review of data driven methods. FEBS Lett 589(23):3516–3526
Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M (2008) Prediction of drug–target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24(13):i232–i240
Yavuz BÇ, Yurtay N, Ozkan O (2018) Prediction of protein secondary structure with clonal selection algorithm and multilayer perceptron. IEEE Access 6:45256–45261
Youjun X, Pei J, Lai L (2017) Deep learning based regression and multiclass models for acute oral toxicity prediction with automatic chemical feature extraction. J Chem Inf Model 57(11):2672–2685
Wu Z, Cheng F, Li J et al (2017) SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning. Brief Bioinform. https:// doi.org/10.1093/bib/bbw012
Zeng X, Zhu S, Liu X et al (2019) DeepDR: a network-based deep learning approach to in silico drug repositioning. Bioinformatics.
Chen H, Cheng F, Li J (2020) IDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding. PLoS Comput Biol. https://doi.org/10.1371/journal.pcbi.1008040
Li B, Dai C, Wang L et al (2020) A novel drug repurposing approach for non-small cell lung cancer using deep learning. PLoS ONE. https://doi.org/10.1371/journal.pone.0233112
Schneider P, Walters WP, Plowright AT et al (2020) Rethinking drug design in the artifcial intelligence era. Nat Rev Drug Discov 19:353–364. https://doi.org/10.1038/s41573-019-0050-3
Chen H, Engkvist O, Wang Y et al (2018) The rise of deep learning in drug discovery. Drug Discov Today 23(6):1241–1250. https://doi.org/10.1016/j.drudis.2018.01.039
Zhang W, Xu H, Li X et al (2020) DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion. Bioinformatics. https://doi.org/10.1093/bioinformatics/ btaa062
Shen Y, Liu T, Chen J et al (2020) Harnessing artifcial intelligence to optimize long-term maintenance dosing for antiretroviral-naive adults with HIV-1 Infection. Adv Ther 3:1900114. https://doi.org/10.1002/adtp.201900114
Mackey, T.K., Liang, B.A.: Global reach of direct-to-consumer advertising using social media for illicit online drug sales. Journal of medical Internet research 15(5) (2013)
Stroppa, A., di Stefano, D., Parrella, B.: Social media and luxury goods counter feit: a growing concern for government, industry and consumers worldwide. The Washington Post (2016)
Hu, X., Tang, J., Zhang, Y., Liu, H.: Social spammer detection in microblogging. In: Twenty-Third International Joint Conference on Artifificial Intelligence (2013)
Zheng, X., Zeng, Z., Chen, Z., Yu, Y., Rong, C.: Detecting spammers on social networks. Neurocomputing 159, 27–34 (2015)
Agrawal, M., Velusamy, R.L.: R-salsa: A spam filtering technique for social networking sites. In: 2016 IEEE Students’ Conference on Electrical, Electronics and Computer Science (SCEECS), pp. 1–7 (2016). IEEE
Jain, G., Sharma, M., Agarwal, B.: Spam detection in social media using convolutional and long short term memory neural network. Annals of Mathematics and Artificial Intelligence 85(1), 21–44 (2019)
Miotto R, Wang F, Wang S, et al. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform 2017; 1–11; doi: 10.1093/bib/bbx044.
Ching T, Himmelstein DS, Beaulieu-Jones BK, et al. Opportunities And Obstacles For Deep Learning In Biology And Medicine. bioRxiv 2017;142760:
Goh GB, Hodas NO, Vishnu A. Deep learning for computational chemistry. J Comput Chem 2017;38(16):1291–307.
Boughorbel S, Jarray F, El-Anbari M. Optimal classifier for imbalanced data using Matthews correlation coefficient metric. PLoS One 2017;12:1–17.
Mervin LH, Afzal AM, Drakakis G, et al. Target prediction utilising negative bioactivity data covering large chemical space. J Cheminform 2015;7:51.
Segler MHS, Kogej T, Tyrchan C, et al. Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS Cent Sci 2018;4(1):120–31.
M. Vettoretti, G. Cappon, A. Facchinetti, and G. Sparacino, “Advanced diabetes management using artifificial intelligence and continuous glucose monitoring sensors,” Sensors, vol. 20, no. 14, p. 3870, 2020.
A. Beneyto, B. W. Bequette, and J. Vehi, “Fault tolerant strategies for automated insulin delivery considering the human component: current and future perspectives,” Journal of diabetes science and technology, vol. 15, no. 6, pp. 1224– 1231, 2021.
X. Sun, M. Rashid, N. Hobbs, R. Brandt, M. R. Askari, and A. Cinar, “Incorporating prior information in adaptive model predictive control for multivariable artificial pancreas systems,” Journal of Diabetes Science and Technology, vol. 16, no. 1, pp. 19–28, 2022.
A. Esteva, B. Kuprel, R. A. Novoa et al., “Dermatologist-level classification of skin cancer with deep neural networks,” Nature, vol. 542, no. 7639, pp. 115–118, 2017.
N. P. Long, K. H. Jung, N. H. Anh et al., “An integrative data mining and omics-based translational model for the identification and validation of oncogenic biomarkers of pancreatic cancer,” Cancers, vol. 11, no. 2, p. 155, 2019.